[1]
Anna Woźniak, “INNOVATIVE DIAGNOSTIC TECHNOLOGIES AND TARGETED THERAPEUTICS IN HYPERTROPHIC CARDIOMYOPATHY: IMPLICATIONS FOR PERSONALIZED PATIENT CARE”, IJITSS, vol. 2, no. 4(48), Dec. 2025.